Evid Invest
Who owns GLUEWhat GLUE owns — n/a

Who owns Monte Rosa Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of GLUE from SEC Form 13F filings across 190 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 190 institutions disclosed 92.4M shares of Monte Rosa Therapeutics, Inc. worth $1.10B — about 90.8% of shares outstanding; the largest disclosed holder is PRICE T ROWE ASSOCIATES INC /MD/. Source: SEC Form 13F filings, parsed by EvidInvest.

190

13F holders

$1.10B

value, 2026 filers

90.8%

of shares outstanding (92.4M sh)

39

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GLUE's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1PRICE T ROWE ASSOCIATES INC /MD/7.4M$87.8M0.0%7.2%-17.0%
2BlackRock, Inc.7.2M$85.8M0.0%7.1%+5.1%
3Vestal Point Capital, LP7.1M$85.1M2.2%7%+55.0%
4NEA Management Company, LLC6.7M$79.8M5.9%6.6%-13.0%
5BAKER BROS. ADVISORS LP4.3M$51.8M0.2%4.3%0.0%
6BVF INC/IL4.3M$51.0M1.7%4.2%-4.1%
7TCG Crossover Management, LLC3.8M$45.1M1.3%3.7%-18.2%
8STATE STREET CORP3.7M$44.4M0.0%3.7%-0.2%
9VANGUARD CAPITAL MANAGEMENT LLC3.5M$41.5M0.0%3.4%+1.8%
10Versant Venture Management, LLC3.2M$37.9M34.8%3.1%0.0%
11SILVERARC CAPITAL MANAGEMENT, LLC3.1M$37.1M4.3%3.1%+180.9%
12MONTANOVA CAPITAL, LLC2.9M$34.8M0.8%2.9%-17.9%
13BRAIDWELL LP2.5M$30.1M1.3%2.5%+3.0%
14GEODE CAPITAL MANAGEMENT, LLC1.9M$22.2M0.0%1.8%-0.3%
15Aisling Capital Management LP1.6M$18.6M6.2%1.5%0.0%
16DIMENSIONAL FUND ADVISORS LP1.4M$16.5M0.0%1.4%+17.3%
17MORGAN STANLEY1.1M$13.7M0.0%1.1%+45.3%
18MPM BIOIMPACT LLC1.1M$13.4M1.0%1.1%-3.1%
19Opaleye Management Inc.1.0M$12.3M1.4%1%+38.9%
20ADAR1 Capital Management, LLC1.0M$12.0M0.5%1%+364.9%
21Frazier Life Sciences Management, L.P.1.0M$11.9M0.3%1%0.0%
22GOLDMAN SACHS GROUP INC871,795$10.4M0.0%0.9%-12.7%
23CITADEL ADVISORS LLC857,107$10.2M0.0%0.8%+424.0%
24Point72 Asset Management, L.P.NEW770,673$9.2M0.0%0.8%new
25Nextech Invest Ltd.761,153$9.1M0.4%0.7%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.